Biodistribution of Amikacin Solid Lipid Nanoparticles after Pulmonary Delivery

The main purpose of the present work was studying the biodistribution of amikacin solid lipid nanoparticles (SLNs) after pulmonary delivery to increase its concentration in the lungs for treatment of cystic fibrosis lung infections and also providing a new method for clinical application of amikacin...

Descripción completa

Detalles Bibliográficos
Autores principales: Varshosaz, J., Ghaffari, S., Mirshojaei, S. F., Jafarian, A., Atyabi, F., Kobarfard, F., Azarmi, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747341/
https://www.ncbi.nlm.nih.gov/pubmed/23984315
http://dx.doi.org/10.1155/2013/136859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747341/
https://www.ncbi.nlm.nih.gov/pubmed/23984315
http://dx.doi.org/10.1155/2013/136859

Ejemplares similares